Support Emotional Wellbeing with Saffron

Introducing our NEW formula, Mood + Emotional Balance, designed to support you. 

The star active ingredient is sunny Saffron, a well-known spice with a long history of use, particularly for a healthy mood. There are many clinical studies that show the effects of Saffron and suggest its success in the treatment of mood and depression. It has been shown to reduce the occurrence of symptoms of mild anxiety, and helps maintain and support emotional wellbeing and healthy emotional and mood balance. Plus, this special formula is also designed for those over 12 years of age.

What is saffron?

Crocus sativus L. is a herb that belongs to the Iridaceae family, commonly known as saffron. Commercial saffron is an expensive traditional spice made up of a dried red stigma that has been used to season and enhance the flavour of food.

Nutritional properties

Its active components have displayed a number of pharmacological benefits such as antidepressant, anti-inflammatory, anti-oxidant and learning and memory-improving effects.

Clinical Studies

Due to the effectiveness of Saffron in the management of depression, displayed in many preclinical studies, a number of clinical trials on Saffron have been conducted over time. 

​​A clinical study assessed the benefit of saffron in the treatment of mild-to-moderate depression in a 6-week double-blind, placebo-controlled and randomized trial. Individuals who received 30mg of saffron per day for 6 weeks showed better outcomes according to the Hamilton Depression Rating Scale compared to those who received placebo. 

In another eight-week, randomised, double-blind, placebo-controlled study, adults with persistent depression, currently taking a pharmaceutical antidepressant were given a placebo or 14mg of a saffron extract (affron®). Depressive symptoms decreased more in participants taking saffron compared with a placebo.


Studies have shown that saffron exerts its effects via antioxidative stress, anti-inflammatory properties and other related pathways. Saffron may alleviate depressive and anxiety-like symptoms in both depression and anxiety patients. Cognitive improvements were also observed in some clinical studies using saffron.

Note: This supplement is not a replacement for any medication or treatments you are following. Do not make any changes to your current routine without the guidance of a qualified health professional. This medicine may not be right for you, always consult a practitioner to assess your individual needs and suitability. If symptoms persist or worsen, see your healthcare professional.

Support is available if you need it

Please know that you are never alone and support is always there for you. If you are experiencing harmful thoughts, we urge you to reach out to your family and friends, and to seek professional help by contacting your doctor, Beyond Blue (1300 22 4636) or Lifeline (13 11 14) as soon as possible. We are here for you and we are all stronger together. We are sending so much love and care to you.


Moshiri M, Vahabzadeh M, Hosseinzadeh H. Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review. Drug Res (Stuttg). 2015 Jun;65(6):287-95.

Siddiqui MJ, Saleh MSM, Basharuddin SNBB, et al. Saffron (Crocus sativus L.): As an Antidepressant. J Pharm Bioallied Sci. 2018;10(4):173-180.

Lopresti AL, Smith SJ, Hood SD, Drummond PD. Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study. J Psychopharmacol. 2019 Nov;33(11):1415-1427. 

Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006 Nov;13(9-10):607-11.

Bian Y, Zhao C, Lee SM. Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside. Front Pharmacol. 2020 Oct 6;11:579052.